We are live on ! Find out more
CNFG

Creegan & Nassoura Financial Group Portfolio holdings

AUM $154M
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+17.18%
3 Year Est. Return
+52.61%
5 Year Est. Return
+77.6%
10 Year Est. Return
AUM
$159M
AUM Growth
+$13.1M
Cap. Flow
+$1.62M
Cap. Flow %
1.02%
Top 10 Hldgs %
35.21%
Holding
80
New
2
Increased
8
Reduced
34
Closed
3

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$1.27M
2
DEO icon
Diageo
DEO
+$1.2M
3
LLY icon
Eli Lilly
LLY
+$209K
4
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$207K
5
BLK icon
Blackrock
BLK
+$24.2K

Sector Composition

Rank Sector Weight
1 Financials 18.82%
2 Industrials 18.1%
3 Healthcare 16.1%
4 Consumer Staples 11.12%
5 Technology 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VO icon
76
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$218K 0.14%
+3,300
New +$207K
LLY icon
77
Eli Lilly
LLY
$1.1T
$206K 0.13%
+232
New +$209K
SOFI icon
78
SoFi Technologies
SOFI
$23.4B
-26,625
Closed -$176K
WM icon
79
Waste Management
WM
$90.6B
-950
Closed -$203K
SOLV icon
80
Solventum
SOLV
$14.5B
-4,335
Closed -$229K

Similar funds

Creegan & Nassoura Financial Group's Q3 2024 Portfolio in Review

As of Q3 2024, Creegan & Nassoura Financial Group held 80 positions worth $159M, up 9% from $146M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Creegan & Nassoura Financial Group's Q3 2024 filing shows 2 new, 8 increased, 34 reduced and 3 closed positions. Its largest new stake was Eli Lilly: 232 shares worth $206K. The largest sale was Solventum, an estimated $229K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Creegan & Nassoura Financial Group's largest Q3 2024 buy was Eli Lilly: 232 shares worth $206K.
  • Creegan & Nassoura Financial Group added most to Chevron in Q3 2024, an estimated $1.27M increase.
  • Creegan & Nassoura Financial Group's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $73.5K.
  • Creegan & Nassoura Financial Group fully exited Solventum in Q3 2024, selling an estimated $229K.
  • Creegan & Nassoura Financial Group's ten largest holdings make up 35% of its $159M portfolio in Q3 2024.
  • Creegan & Nassoura Financial Group opened 2 new positions and closed 3 in Q3 2024.
  • Creegan & Nassoura Financial Group's portfolio value rose 9% quarter-over-quarter to $159M.

Based on Creegan & Nassoura Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.